Pharma & Biotech

Natera finds itself at a fascinating crossroads. The diagnostics company is posting unexpectedly robust revenue and achieving breakthroughs in early...

A significant regulatory milestone in Canada has propelled Iovance Biotherapeutics' stock upward, with Health Canada granting market authorization for the...

Mainz-based biotechnology firm BioNTech, once celebrated as a pandemic-era vaccine champion, is executing a strategic pivot with billion-dollar implications. As...

Investment firm Guggenheim has issued a bullish update on Assembly Biosciences, increasing its price target for the biopharmaceutical company to...

Microbot Medical's stock experienced significant upward momentum following a landmark regulatory achievement. The company announced that the U.S. Food and...

Stereotaxis has announced three significant developments that signal a powerful acceleration phase for the robotics-assisted surgery specialist. The company has...

Pharmaceutical giants Pfizer and BioNTech have announced positive clinical trial results for their updated COVID-19 vaccine, timed to coincide with...

Pharmaceutical giant Viatris has notched a significant legal victory in Europe, successfully defending the trademark protection for its blockbuster anxiety...

Shares of Tenaya Therapeutics are experiencing a powerful upward trajectory, fueled by significant advancements within its clinical development pipeline. The...

Biopharmaceutical company Replimune finds itself confronting significant legal challenges as multiple shareholder class action lawsuits emerge in the wake of...